BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin
88 results:

  • 1. Genetic disorders and insulinoma/glucagonoma.
    Marini F; Giusti F; Brandi ML
    Endocr Relat Cancer; 2024 May; 31(5):. PubMed ID: 38552306
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
    Yang Y; Lee J; Woo CG; Lee OJ; Son SM
    Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An Integrated Multi-Omics Analysis Identifying Immune Subtypes of Pancreatic cancer.
    Su Y; Wang F; Lei Z; Li J; Ma M; Yan Y; Zhang W; Chen X; Xu B; Hu T
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203311
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
    Navale P; Chatterjee D; Itani M; Trikalinos NA
    Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective.
    Werle SD; Ikonomi N; Lausser L; Kestler AMTU; Weidner FM; Schwab JD; Maier J; Buchholz M; Gress TM; Kestler AMR; Kestler HA
    NPJ Syst Biol Appl; 2023 Jun; 9(1):22. PubMed ID: 37270586
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy and safety of anlotinib-based chemotherapy for locally advanced or metastatic anaplastic thyroid carcinoma.
    Zheng X; Wang J; Ye T; Tang W; Pan X; Wang S; Liu J
    Endocrine; 2023 Sep; 81(3):540-546. PubMed ID: 37219702
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Significance of the Intercarotid Distances for Transsphenoidal Pituitary Surgery: A Magnetic Resonance Imaging Study.
    Tsuneoka H; Tosaka M; Yamaguchi R; Tanaka Y; Mukada N; Shimauchi-Ohtaki H; Aihara M; Shimizu T; Yoshimoto Y
    World Neurosurg; 2023 Jul; 175():e704-e712. PubMed ID: 37044207
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Synthesis and Antiproliferative Activity of Steroidal Diaryl Ethers.
    Kovács É; Ali H; Minorics R; Traj P; Resch V; Paragi G; Bruszel B; Zupkó I; Mernyák E
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770863
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Anti-Proliferative Acyl Phenols and Arylnonanoids from the Fruit Rind of Myristica malabarica lam.
    Bauri AK; Du Y; Brodie PJ; Foro S; Kingston DGI
    Chem Biodivers; 2022 Dec; 19(12):e202200343. PubMed ID: 36263966
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer.
    Lu SY; Hua J; Liu J; Wei MY; Liang C; Meng QC; Zhang B; Yu XJ; Wang W; Xu J
    BMC Med Genomics; 2022 Oct; 15(1):218. PubMed ID: 36261830
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of the anti-diabetic effect of biogenic silver nanoparticles and intervention in PPARγ gene regulation.
    Sengani M; V B; Banerjee M; Choudhury AA; Chakraborty S; Ramasubbu K; Rajeswari V D; Al Obaid S; Alharbi SA; Subramani B; Brindhadevi K
    Environ Res; 2022 Dec; 215(Pt 3):114408. PubMed ID: 36154863
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic Value, Immune Signature, and Molecular Mechanisms of the PHLDA Family in Pancreatic Adenocarcinoma.
    Duan Y; Du Y; Gu Z; Zheng X; Wang C
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142223
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.
    Ruggeri RM; Benevento E; De Cicco F; Fazzalari B; Guadagno E; Hasballa I; Tarsitano MG; Isidori AM; Colao A; Faggiano A;
    J Endocrinol Invest; 2023 Feb; 46(2):213-234. PubMed ID: 36038743
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tuberous sclerosis complex-associated nonfunctional pancreatic neuroendocrine tumors: Management and surgical outcomes.
    Evans LM; Geenen KR; O'Shea A; Hedgire SS; Ferrone CR; Thiele EA
    Am J Med Genet A; 2022 Sep; 188(9):2666-2671. PubMed ID: 35612824
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular and immunohistochemical characterisation of mesothelioma of the tunica vaginalis
    Anderson WJ; Sholl LM; Fletcher CDM; Schulte S; Wang LJ; Maclean FM; Hirsch MS
    Histopathology; 2022 Jul; 81(1):65-76. PubMed ID: 35460532
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
    Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
    Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma.
    Lawson BC; Yang RK; Euscher ED; Ramalingam P; Malpica A
    Hum Pathol; 2021 Sep; 115():76-83. PubMed ID: 34153306
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Phakomatoses and endocrine gland Tumors: Noteworthy and (Not so) Rare Associations.
    Chevalier B; Dupuis H; Jannin A; Lemaitre M; Do Cao C; Cardot-Bauters C; Espiard S; Vantyghem MC
    Front Endocrinol (Lausanne); 2021; 12():678869. PubMed ID: 34025587
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data.
    Tian X; Xu WH; Anwaier A; Wang HK; Wan FN; Cao DL; Luo WJ; Shi GH; Qu YY; Zhang HL; Ye DW
    J Cell Mol Med; 2021 Apr; 25(8):3898-3911. PubMed ID: 33626208
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or Ovarian cancer, 2012-2019.
    Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
    J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.